Vaerlose, Denmark

Gina Engslev Fischer

USPTO Granted Patents = 14 

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 159(Granted Patents)


Location History:

  • V{acute over (æ)}rløse, DK (2013)
  • Væ rløse, DK (2012 - 2017)
  • Vaerlose, DK (2013 - 2017)
  • Vaerløse, DK (2013 - 2018)

Company Filing History:


Years Active: 2012-2018

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations in Opioid Delivery Systems by Gina Engslev Fischer

Introduction

Gina Engslev Fischer, a distinguished inventor based in Vaerlose, Denmark, is recognized for her significant contributions to the field of pharmaceutical compositions, particularly in innovative opioid delivery systems. With a portfolio of 14 patents, Fischer’s work reflects her commitment to improving patient care through advanced drug delivery technologies.

Latest Patents

Among her notable inventions are two groundbreaking patents focused on controlled release systems for opioids. The first patent, titled "Morphine Controlled Release System," describes an oral pharmaceutical composition designed for the controlled release of an opioid. This composition features an erodible matrix that combines polymers and an opioid, complemented by a specialized coating with openings that expose the matrix surface. This unique design enables a controlled release profile, achieving approximately 75% w/w opioid release within 4-10 hours under dissolution testing conditions.

The second patent, referred to as "Opioid Polymer Release System," details a pharmaceutical composition that allows the active substance to be released into an aqueous medium through the erosion of the matrix's surface. Similar to her first patent, this composition includes a mixture of polymers and active ingredients, alongside a protective coating. Both inventions are pivotal in addressing the challenges faced in opioid medication administration.

Career Highlights

Gina Fischer's career has been marked by her collaboration with prominent companies in the pharmaceutical industry, including Egalet Ltd. and Egalet A/S. Her work in these organizations has facilitated the advancement of innovative solutions in opioid medication, further establishing her as a leading figure in pharmaceutical development.

Collaborations

Throughout her professional journey, Fischer has collaborated with notable colleagues, including Lillian Slot and Daniel K. Bar-Shalom. Such partnerships have enriched her research and development endeavors, promoting a culture of innovation and teamwork in tackling complex pharmaceutical challenges.

Conclusion

Gina Engslev Fischer's contributions to the field of pharmaceutical compositions, particularly her advancements in opioid controlled release systems, underline the importance of innovation in healthcare. With her extensive portfolio of patents and collaborative efforts, Fischer continues to pave the way for advancements that enhance patient outcomes and broaden the scope of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…